Animal Model Market to Reach US$ 2.9 Billion by 2032 CAGR of 5.5%

The animal model market is projected to reach a value of US$ 1.7 Billion in 2022 and is anticipated to grow to US$ 2.9 Billion by 2032, showcasing a compound annual growth rate (CAGR) of 5.5% from 2022 to 2032.

The animal model market has witnessed significant growth and transformation in recent years, driven by the increasing demand for preclinical testing in pharmaceutical and biotechnological research. Animal models, including mice, rats, rabbits, and non-human primates, play a crucial role in understanding human physiology, studying diseases, and evaluating potential therapeutic interventions. This market has become an indispensable component of the drug development process, offering valuable insights before moving to human clinical trials.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1590

Market Overview:

The animal model market has experienced robust growth, propelled by advancements in genetic engineering, the rise in research and development activities, and the expanding pharmaceutical and biotechnology sectors. Animal models are extensively used for studying complex biological processes, drug safety assessments, and the development of novel therapies. The increasing prevalence of chronic diseases and the need for personalized medicine have further fueled the demand for sophisticated animal models.

Market Opportunity:

The animal model market presents ample opportunities for growth, particularly with the growing emphasis on precision medicine and the need for more accurate disease models. As the pharmaceutical industry continues to invest heavily in research and development, the demand for specialized and genetically modified animal models is expected to soar. Additionally, the emergence of new technologies, such as CRISPR-Cas9 gene editing, has opened up avenues for creating precise and customized animal models, providing researchers with unprecedented tools for studying specific genetic mutations and diseases.

Market Challenges:

Despite the promising growth prospects, the animal model market faces certain challenges. Ethical concerns regarding the use of animals in research have led to increased scrutiny and calls for alternative testing methods. Additionally, the high costs associated with maintaining and breeding specific strains of animals, as well as the time-consuming nature of generating genetically modified models, pose challenges for researchers and industry players. Striking a balance between ethical considerations and the necessity for animal models remains a complex issue in the field.

Key Players:

Genoway SA
Eurofins Scientific SE
Crown Bioscience Inc.
Envigo CRS SA
Transposagen Biopharmaceuticals, Inc.
Trans Genic Inc.
The Jackson Laboratory
Horizon Discovery Group Plc.
Charles River Laboratories International Inc.

Competitive Landscape:

To enhance their market reach and solidify their position in the industry, prominent suppliers of animal model systems are actively pursuing strategic acquisitions, mergers, collaborations, and partnerships. The recent influx of investments from major corporations has presented lucrative prospects for the sector's global expansion. Noteworthy advancements include:

In April 2022, Taconic Biosciences and Biomodels joined forces to establish the Taconic-Biomodels Microbiome Initiative (TBMI). This initiative aims to provide researchers with seamless access to comprehensive solutions for germ-free and gnotobiotic microbiome studies, encompassing everything from study design to data analysis. By integrating access to relevant disease models, germ-free animal production, and in-vivo research design, execution, and analytics, TBMI eliminates longstanding obstacles that have hindered microbiome research.

In September 2021, Inotiv Inc. and Envigo announced a mutually beneficial agreement. Inotiv Inc. has agreed to acquire Envigo, enabling both companies to gain improved access to a wide range of products and services throughout the entire discovery and non-clinical development process. This acquisition consolidates their offerings within a single organization, fostering enhanced efficiency and effectiveness in their operations.

Key Segments Covered in the Animal Model Industry Report

Animal Model Market by Species :
Rat Models
Mice Models
Guinea Pig Models
Rabbit Models
Monkey Models
Dog Models
Pig Models
Cat Models
Other Animal Species Models

Animal Model by Application :
Animal Models for Basic & Applied Research
Animal Models for Drug Discovery/Development

Animal Model by End User :
Academic & Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (Cros)
Other End Users

Animal Model by Region :
North America Animal Model Market
Latin America Animal Model Market
Europe Animal Model Market
South Korea Animal Model Market
APAC Animal Model Market
Middle East & Africa Animal Model Market

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1590

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.